Report - HIGHLIGHTS OF PRESCRIBING INFORMATION · Resume treatment when the adverse reaction fully resolves, returns to baseline, or improves to Grade 1. Reinstitute GILOTRIF at a reduced

Please pass captcha verification before submit form